Literature DB >> 6391655

In vivo assessment of tumor-induced nonspecific suppression of contact sensitivity. II. Regulation by cytokines and T cells via adoptive transfer.

R E Garner, A P Malick, K M Connolly, K D Elgert.   

Abstract

Normal BALB/c mice were assessed for 2,4-dinitrofluorobenzene (DNFB)-induced contact sensitivity following adoptive transfer of macrophages (Mo). T cells, or their derived products, from normal or tumor-bearing hosts (TBH). Contact sensitivity (CS) was measured by a quantitative radioisotopic ear assay, a total in vivo system based on localization of IP-injected iodinated human serum albumin [( 125I]HSA) in the DNFB-challenged ear. Adoptive transfer of low or high doses of TBH T cells or their derived supernatants into normal recipients suppressed their responsiveness, while Mo supernatants enhanced it. Moreover, in all cases adoptive transfer of TBH cells or supernatants resulted in a lower CS response than did their normal counterparts. These results further corroborate our previous in vitro data indicating that T cells, or Mo and T cell soluble products, possess immunoregulatory capabilities in vivo.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6391655     DOI: 10.1007/BF00205748

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  21 in total

1.  Concentration-dependent role of macrophages in mixed lymphocyte reaction regulation: elaboration of nondialyzable heat-stable inhibitor and heat-labile enhancing factors.

Authors:  K M Connolly; K D Elgert
Journal:  J Reticuloendothel Soc       Date:  1979-03

2.  Suppressor cells in the spleens of tumor-bearing mice: enrichment by centrifugation on hypaque-ficoll and characterization of the suppressor population.

Authors:  B L Pope; R B Whitney; J G Levy; D G Kilburn
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

3.  Inhibition of mitogen and immune blastogenesis by two distinct populations of supressor cells present in the spleens of fibrosarcoma-bearing mice: adoptive transfer of suppression.

Authors:  W L Farrar; K D Elgert
Journal:  Int J Cancer       Date:  1978-08-15       Impact factor: 7.396

4.  In vitro immune blastogenesis during contact sensitivity in tumor-bearing mice. I. Description of progressive impairment and demonstration of splenic suppressor cells.

Authors:  K D Elgert; W L Farrar
Journal:  Cell Immunol       Date:  1978-10       Impact factor: 4.868

5.  The stimulatory effects of bearing primary methylcholanthrene-induced tumors upon the murine lymphoreticular system.

Authors:  R T Smith; S Konda
Journal:  Int J Cancer       Date:  1973-11-15       Impact factor: 7.396

Review 6.  Immunoregulatory T-cell pathways.

Authors:  D R Green; P M Flood; R K Gershon
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

7.  Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages.

Authors:  K D Elgert; W L Farrar
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

8.  Immunoregulation of the mixed lymphocyte reaction by macrophage-derived factors: functional and biochemical separation of enhancing and inhibitory factors.

Authors:  K M Connolly; K D Elgert; J M Conroy; S N Vogel; R B Rutherford
Journal:  Immunobiology       Date:  1983-03       Impact factor: 3.144

9.  In vivo assessment of tumor-induced nonspecific suppression of contact sensitivity. I. Correlation with in vitro studies.

Authors:  K D Elgert
Journal:  Cell Immunol       Date:  1980-02       Impact factor: 4.868

10.  An inhibitor of cell proliferation released by cultures of macrophages.

Authors:  J Calderon; R T Williams; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

View more
  1 in total

1.  Splenocytes from tumor-bearing Corynebacterium parvum treated mice maintain interleukin-2 and -3 activity.

Authors:  A M Roberson; K D Elgert
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.